VTRS Viatris
$17.54 -0.45%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
-0.45%
YTD
+73.00%
P/E
—
P/B
0.97
ROE
-2.8%
Div yield
5.1%
Beta
0.7
Market cap
$20.3B
RSI (14)
56
Next earnings
Nov 4, 2026
Previous session
close of Oct 6, 2026 · EOD, no live order bookOpen
$17.77
Close
$17.54
VWAP (n/a)
—
Day high
$17.87
Day low
$17.31
Volume
6.7M
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
VTRS vs. AVTR: Which Stock Is the Better Value Option?
Yahoo Finance · Oct 6
Should Value Investors Buy Viatris (VTRS) Stock?
Yahoo Finance · Oct 6
Harrow Closes Acquisition of TYRVAYA®
Yahoo Finance · Oct 5
Viatris to Report Third-Quarter 2026 Financial Results on November 5, 2026
Yahoo Finance · Oct 5
Is Viatris Stock Outperforming the S&P 500?
Yahoo Finance · Sep 24
Viatris (VTRS) Wins Japan WAKIX Approval. Can it Build a Meaningful Specialty Business?
Yahoo Finance · Sep 21
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
10-Q Aug 6, 2026 View → 8-K Aug 6, 2026 View → 8-K Jul 1, 2026 View → 8-K Jun 18, 2026 View → 8-K Jun 15, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell VTRS. Try it in the Lab to size a position and see the risk.